Kelly L Bolton

14PUBLICATIONS
182CO-AUTHORS
Haematological tumoursHaematologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 28, 2026
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.

|May 21, 2026
Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk.

|Mar 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis.

Irenaeus C C Chan, Pu Zhang, Xiangyu Pan

|Jul 15, 2025
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy.

Jie Liu, Duc Tran, Liying Xue

|Apr 30, 2025
Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification.

Aubrey K Hubbard, Derek W Brown, Jie Liu

|Sep 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201).

Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan

Pageof 3

Frequent Collaborators

6 joint publications

Yin Cao

6 joint publications

Duc Tran

6 joint publications

Irenaeus C Chan

5 joint publications

Jie Liu